572 related articles for article (PubMed ID: 15860756)
1. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
[TBL] [Abstract][Full Text] [Related]
2. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs.
Cui R; Tieu B; Recinos A; Tilton RG; Brasier AR
Circ Res; 2006 Sep; 99(7):723-30. PubMed ID: 16960103
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.
Sahar S; Reddy MA; Wong C; Meng L; Wang M; Natarajan R
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1528-34. PubMed ID: 17495236
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-kappaB and AP-1 in vascular smooth muscle cells.
Chen Y; Currie RW
Cardiovasc Res; 2006 Jan; 69(1):66-75. PubMed ID: 16061216
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
[TBL] [Abstract][Full Text] [Related]
8. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate inhibits interleukin-6- and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells.
Peng N; Liu JT; Guo F; Li R
Life Sci; 2010 Mar; 86(11-12):410-5. PubMed ID: 20100497
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
[TBL] [Abstract][Full Text] [Related]
12. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin.
Yoshida T; Hoofnagle MH; Owens GK
Circ Res; 2004 Apr; 94(8):1075-82. PubMed ID: 15016729
[TBL] [Abstract][Full Text] [Related]
13. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
Kai H; Fukui T; Lassègue B; Shah A; Minieri CA; Griendling KK
Mol Pharmacol; 1996 Jan; 49(1):96-104. PubMed ID: 8569718
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.
Hu ZW; Kerb R; Shi XY; Wei-Lavery T; Hoffman BB
J Pharmacol Exp Ther; 2002 Nov; 303(2):563-73. PubMed ID: 12388637
[TBL] [Abstract][Full Text] [Related]
15. Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Ren XY; Ruan QR; Zhu DH; Zhu M; Qu ZL; Lu J
Sheng Li Xue Bao; 2007 Jun; 59(3):339-44. PubMed ID: 17579790
[TBL] [Abstract][Full Text] [Related]
16. Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells.
Yin BL; Hao H; Wang YY; Jiang YJ; Xue S
Inflamm Res; 2009 Feb; 58(2):67-73. PubMed ID: 19184356
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
18. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts.
Li JM; Cui TX; Shiuchi T; Liu HW; Min LJ; Okumura M; Jinno T; Wu L; Iwai M; Horiuchi M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):80-4. PubMed ID: 14592853
[TBL] [Abstract][Full Text] [Related]
19. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.
Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S
Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A
Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
